mefloquine has been researched along with fluorodeoxyglucose f18 in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Fujii, H; Matsumoto, M; Morimoto, A; Nakamichi, K; Nakamura, T; Saijo, M; Ueno, H; Yukitake, M | 1 |
Hatanaka, KC; Hirotani, M; Kano, T; Matsushima, M; Minami, N; Nakamichi, K; Nonaka, T; Saijo, M; Sasaki, H; Sasamori, T; Sato, K; Shiga, T; Shimizu, Y; Shirai, S; Takahashi, I; Tanaka, S; Yabe, I | 1 |
2 other study(ies) available for mefloquine and fluorodeoxyglucose f18
Article | Year |
---|---|
[Ineffective mefloquine therapy in progressive multifocal leukoencephalopathy complicated with malignant lymphoma: finding and usefulness of susceptibility-weighted imaging].
Topics: Disease Susceptibility; Female; Fluorodeoxyglucose F18; Humans; Leukoencephalopathy, Progressive Multifocal; Lymphoma, B-Cell; Mefloquine; Middle Aged; Positron-Emission Tomography; Treatment Failure | 2013 |
Usefulness of 11C-methionine-positron emission tomography for the diagnosis of progressive multifocal leukoencephalopathy.
Topics: Aged; Aged, 80 and over; Antimalarials; Brain; Disease Progression; Early Diagnosis; Female; Fluorodeoxyglucose F18; Humans; JC Virus; Leukoencephalopathy, Progressive Multifocal; Male; Mefloquine; Methionine; Middle Aged; Positron-Emission Tomography; Prognosis; Treatment Outcome | 2014 |